Kane Biotech (Kane Biotech) Institutional Ownership : 0.65% (As of May. 17, 2024)

View and export this data going back to 2007. Start your Free Trial

What is Kane Biotech Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Kane Biotech's institutional ownership is 0.65%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Kane Biotech's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Kane Biotech's Float Percentage Of Total Shares Outstanding is 0.00%.

Kane Biotech Institutional Ownership Historical Data

The historical data trend for Kane Biotech's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kane Biotech Institutional Ownership Chart

Kane Biotech Historical Data

The historical data trend for Kane Biotech can be seen below:

	2015-10-31	2015-11-30	2015-12-31	2016-01-31	2016-02-29	2016-03-31	2016-04-30	2016-05-31	2016-06-30	2016-08-31
Institutional Ownership	1.15	1.15	1.09	1.09	1.09	1.05	1.05	1.05	0.65	0.65

Kane Biotech Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

Kane Biotech (Kane Biotech) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kane Biotech Inc (OTCPK:KNBIF) » Definitions » Institutional Ownership

Comparable Companies

Traded in Other Exchanges

KNE:Canada

Address

290-100 Innovation Drive, Winnipeg, MB, CAN, R3T 6G2

Website

https://www.kanebiotech.com

Kane Biotech Inc is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The company has a portfolio of biotechnologies, intellectual property and products developed by its own biofilm research expertise and acquired from research institutions. The Company has a separate operating segment for its Stem Animal Health subsidiary, which operates the animal health business. StrixNB, DispersinB, Aledex, bluestem, bluestem, silkstem, goldstem, coactiv+, DermaKB and DermaKB Biofilm are trademarks of the company. The firm is also engaged in the animal health business through its Stem Animal Health subsidiary.